PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities

Autor: Liu, Xiaohong, Mei, Wuxuan, Zhang, Pengfei, Zeng, Changchun
Zdroj: In Pharmacological Research April 2024 202
Databáze: ScienceDirect